Skip to Main Content

Try STAT+ TODAY

diabetes

Most Read

The Readout LOUD By Adam Feuerstein and Meg Tirrell

Listen: What’s next for Roche, a debate over second boosters, & Vertex’s recent success

First Opinion By Alina Bills

Turning to social media to get affordable insulin: a clear sign of a broken health care system

failed obesity science

First Opinion By Gary Taubes

How a ‘fatally, tragically flawed’ paradigm has derailed the science of obesity

jerome & aubert

STAT Madness By Rebecca Sohn

Researchers pursuing novel treatments for herpes infections and diabetes win STAT Madness

Laura Woerner

Health By Elizabeth Cooney

People with type 1 diabetes have a higher risk of dying from Covid-19. Why are they lower on CDC’s vaccine priority list?

Blood sugar monitor - finger stick

Health By Elizabeth Cooney

Why people with diabetes are being hit so hard by Covid-19

Emma Klek - TD1 journey

Health By Nicholas Florko

See one woman’s complicated, costly journey to a Canadian strip mall pharmacy — all for cheaper insulin

Insulin Pens

First Opinion By John LaMattina

Today’s insulin isn’t what Banting and Best developed. It’s far, far better

All Coverage

Politics By Rachel Cohrs

Would drugmakers lower their insulin prices if Congress asks nicely?

Eli Lilly headquarters

Biotech By Matthew Herper

With new diabetes drug data, Eli Lilly is taking aim at obesity

advertisement

Politics By Nicholas Florko

Human Rights Watch says unaffordable U.S. insulin is a human rights abuse

Susan Collins

Politics By Rachel Cohrs

New bipartisan insulin policy aims to entice drugmakers to lower prices

Exclusive By Matthew Herper

Douglas Melton, noted stem cell researcher, leaves Harvard for Vertex to create diabetes treatments

First Opinion Podcast

First Opinion Podcast By Patrick Skerrett

Listen: The ‘underground market’ for insulin and diabetes supplies

Insulin Pens

Pharmalot By Ed Silverman

Civica Rx has an ambitious plan to make low-cost insulin for all Americans. But can it work?

Eli Lilly headquarters

Pharmalot By Ed Silverman

Michigan attorney general pursues investigation into Lilly’s ‘grossly’ excessive insulin prices

Emma Klek - TD1 journey

Health Tech By Katie Palmer

For digital diabetes care, is more data always better?

A Eye

Health Tech By Katie Palmer

Medicine’s first autonomous AI could prevent blindness due to diabetes — if it can reach those most in need

FDA-Blood Sugar Monitor

Health Tech By Katie Palmer

Carbon Health launches a program for continuous glucose monitoring to curb diabetes risk

Pharmalot By Ed Silverman

Lilly cuts the wholesale price on some insulin products, but impact is likely to be limited

Global obesity

Health By Elizabeth Cooney

As diabetes prevalence rises in children and adults, screening age drops to 35 for overweight adults

hip insulin pump

Health Tech By Katie Palmer

Artificial pancreases were a breakthrough for type 1 diabetes. The research in type 2 is just beginning

Judge's gavel

Pharmalot By Ed Silverman

Insulin makers and pharmacy benefit managers must face racketeering claims in a lawsuit

stomach cgm

Health Tech By Katie Palmer

Demand is growing for continuous glucose monitoring for type 2 diabetes. Primary care doctors need to prepare

Walmart 2020

Pharmalot By Ed Silverman

‘This is not enough’: Walmart’s plan to sell another private label insulin is met with skepticism

Blood sugar monitor - finger stick

Health Tech By Katie Palmer

Experts debate the value of digital coaching for type 2 diabetes

Erich Huang

Exclusive By Erin Brodwin

Onduo’s new exec on Google’s data skills, real-world evidence, and moving the needle on outcomes

digital diabetes care

Exclusive By Erin Brodwin

Carbon Health dives into digital diabetes care with virtual clinic acquisition

What measuring blood sugar in real time means to patients

Health Tech By Elizabeth Cooney

Measuring blood sugar in real time is a game changer for patients — and a health tech success story

Glucose patch

Health Tech By Katie Palmer

Glucose monitors revolutionized diabetes care. Now digital health startups want to bring them to the masses

Insulin in Minnesota

Pharmalot By Ed Silverman

Congressional lawmakers urge FTC to investigate insulin makers over their pricing

Diabetes Transplants

Health Tech By Katie Palmer

4 health startups racing to shake up diabetes care

Judge's gavel

Pharmalot By Ed Silverman

Insulin makers win a significant round in Minnesota lawsuit accusing them of racketeering